The production of aberrant hematopoietic stem cell development, hematological malignancies, autoimmunity, and some immunodeficiency disorders has been demonstrated to require abnormal activation of JAK/STAT signaling by JAK mutations or constitutive TYK2 signaling [42]. This evidence concerns the gene TYK2 and immunodeficiency disease.